Literature DB >> 15920177

Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction.

Douglas J McCrath1, Elisabetta Cerboni, Robert J Frumento, Andrew L Hirsh, Elliott Bennett-Guerrero.   

Abstract

Postoperative thrombotic complications increase hospital length of stay and health care costs. Given the potential for thrombotic complications to result from hypercoagulable states, we sought to determine whether postoperative blood analysis using thromboelastography could predict the occurrence of thrombotic complications, including myocardial infarction (MI). We prospectively enrolled 240 patients undergoing a wide variety of surgical procedures. A cardiac risk score was assigned to each patient using the established revised Goldman risk index. Thromboelastography was performed immediately after surgery and maximum amplitude (MA), representing clot strength, was determined. Postoperative thrombotic complications requiring confirmation by a diagnostic test were assessed by a blinded observer. Ten patients (4.2%) suffered a total of 12 postoperative thrombotic complications. The incidence of thrombotic complications with increased MA (8 of 95 = 8.4%) was significantly (P = 0.0157) more frequent than that of patients with MA < or =68 (2 of 145 = 1.4%). Furthermore, the percentage suffering postoperative MI in the increased MA group (6 of 95 = 6.3%) was significantly larger than that in the MA < or =68 group (0 of 145 = 0%) (P = 0.0035). In a multivariate analysis, increased MA (P = 0.013; odds ratio, 1.16; 95% confidence interval, 1.03-1.20) and Goldman risk score (P = 0.046; odds ratio, 2.39; 95% confidence interval, 1.02-5.61) both independently predicted postoperative MI. A postoperative hypercoagulable state as determined by thromboelastography is associated with postoperative thrombotic complications, including MI, in a diverse group of surgical patients.

Entities:  

Mesh:

Year:  2005        PMID: 15920177     DOI: 10.1213/01.ANE.0000155290.86795.12

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  61 in total

1.  Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot Study.

Authors:  Alexander A Hanke; Ulf Herold; Daniel Dirkmann; Konstantinos Tsagakis; Heinz Jakob; Klaus Görlinger
Journal:  Transfus Med Hemother       Date:  2012-03-15       Impact factor: 3.747

2.  Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting.

Authors:  Louise Bochsen; Lisbeth Bredahl Rosengaard; Allan Bybeck Nielsen; Daniel A Steinbrüchel; Pär I Johansson
Journal:  J Extra Corpor Technol       Date:  2009-03

Review 3.  [Coagulation management in patients with liver disease].

Authors:  A Bienholz; A Canbay; F H Saner
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-05       Impact factor: 0.840

Review 4.  Coagulopathy after severe pediatric trauma.

Authors:  Sarah C Christiaans; Amy L Duhachek-Stapelman; Robert T Russell; Steven J Lisco; Jeffrey D Kerby; Jean-François Pittet
Journal:  Shock       Date:  2014-06       Impact factor: 3.454

5.  Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial.

Authors:  Jie-Qiong Song; Li-Zhen Xuan; Wei Wu; Jun-Feng Huang; Ming Zhong
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

6.  Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery.

Authors:  Pilar Taura; Eva Rivas; Graciela Martinez-Palli; Annabel Blasi; Juan Carlos Holguera; Jaume Balust; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2013-09-17       Impact factor: 4.584

7.  C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.

Authors:  Rolf P Kreutz; Janelle Owens; Jeffrey A Breall; Deshun Lu; Elisabeth von der Lohe; Islam Bolad; Anjan Sinha; David A Flockhart
Journal:  Blood Coagul Fibrinolysis       Date:  2013-04       Impact factor: 1.276

8.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

9.  Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis.

Authors:  David R Altmann; Wolfgang Korte; Micha T Maeder; Thomas Fehr; Philipp Haager; Hans Rickli; Gian-Reto Kleger; Regulo Rodriguez; Peter Ammann
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

10.  Patient with recent coronary artery stent requiring major non cardiac surgery.

Authors:  Usha Kiran; Neeti Makhija
Journal:  Indian J Anaesth       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.